Patient_201_011_preRelapse
Homo sapiens
Protocols: Bone marrow samples were collected from patients at defined time points as part of a clinical trial protocol (AG-221-C-001) with informed consent. The focus of this study was on patients who had achieved complete remission in response to Enasidenib but subsequently relapsed. Bone marrow samples included in this dataset were collected before and after relapse. Patients were treated with Enasidenib according to clinical trial protocols of 100mg once daily of Enasidenib. Total RNA was extracted using Norgen RNA/DNA extraction kit. Copy DNA libraries constructed using Clontech SMARTer low input kit, followed by tagmentation and indexing using Illumina Nextera kit.
ENA-FIRST-PUBLIC
2018-08-08T17:02:08Z
ENA-LAST-UPDATE
2018-04-11T09:54:42Z
External Id
SAMEA1100286
INSDC center name
Team 163, Cancer Ageing and Somatic Mutations
INSDC first public
2018-08-08T17:02:08Z
INSDC last update
2018-04-11T09:54:42Z
INSDC status
public
Submitter Id
E-MTAB-6660:Patient_201_011_preRelapse
broker name
ArrayExpress
clinical history
pre relapse
common name
human
developmental stage
adult
disease
acute myeloid leukemia
genotype
mutation in IDH2
individual
2
organism part
bone marrow
sample name
E-MTAB-6660:Patient_201_011_preRelapse
scientific_name
Homo sapiens
sex
female